Methyl iodide → N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methyl-2-piperidyl)-6-oxo-pyrimidine-4-carboxamide

HRID 1161905Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1161905
C([O:9][C:10]1[C:15](=[O:16])[N:14]([CH3:17])[C:13]([CH:18]2[CH2:23][CH2:22][CH2:21][CH2:20][NH:19]2)=[N:12][C:11]=1[C:24]([O:26]C)=O)(=O)C1C=CC=CC=1.[CH2:28](OC(N1CCCCC1C(O)=O)=O)C1C=CC=CC=1.C(N(CC)CC)C.CI.[F:56][C:57]1[CH:64]=[CH:63][C:60]([CH2:61][NH2:62])=[CH:59][CH:58]=1>C1COCC1.C(#N)C.O>[F:56][C:57]1[CH:64]=[CH:63][C:60]([CH2:61][NH:62][C:24]([C:11]2[N:12]=[C:13]([CH:18]3[CH2:23][CH2:22][CH2:21][CH2:20][N:19]3[CH3:28])[N:14]([CH3:17])[C:15](=[O:16])[C:10]=2[OH:9])=[O:26])=[CH:59][CH:58]=1

Komponenten

8

Versuchsvorschrift

Methyl 5-(benzoyloxy)-1-methyl-6-oxo-2-piperidin-2-yl-1,6-dihydropyrimidine-4-carboxylate (prepared from 1-(benzyloxycarbonyl)piperidine-2-carboxylic acid by procedures similar to those set forth in Examples 1 or 2 in combination with a deprotection step) was suspended in THF and treated with 3 eq. of triethylamine and 3 eq. of methyl iodide at 40° C. After stirring for 5 h, THF was evaporated and residue poured into EtOAc and washed with brine. Organic phase was dried (Na2SO4), filtered and concentrated under reduced pressure. The oily residue was taken into EtOAc and treated with 3 eq. of 4-fluorobenzylamine at 90° C. for 0.5 h. The title product was isolated as its trifluoroacetic salt by preparative RP-HPLC (C18, 5 μM, acetonitrile/water containing 0.1% TFA as eluant).

Aufarbeitung

  1. customTHF was evaporated
  2. additionresidue poured into EtOAc
  3. washwashed with brine
  4. dry with materialOrganic phase was dried (Na2SO4)
  5. filtrationfiltered
  6. concentrationconcentrated under reduced pressure

Quellen und Nachweise

ORD-Eintrag
ord-1ed7869ede5245a09cbeaaeffe35d52b
Quelldatensatz
uspto-grants-2010_10
Patentnummer
US07820660B2

Notizen zur Reaktion

Wird geladen…